Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
377
-
Total 13F shares, excl. options
-
109M
-
Shares change
-
+1.3M
-
Total reported value, excl. options
-
$15.3B
-
Value change
-
+$197M
-
Put/Call ratio
-
0.62
-
Number of buys
-
189
-
Number of sells
-
-138
-
Price
-
$141.19
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2021
448 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2021.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 377 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109M shares
of 132M outstanding shares and own 82.67% of the company stock.
Largest 10 shareholders include FMR LLC (17.5M shares), VANGUARD GROUP INC (10.6M shares), BAILLIE GIFFORD & CO (10.1M shares), WELLINGTON MANAGEMENT GROUP LLP (9.15M shares), BlackRock Inc. (9.01M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.58M shares), Dodge & Cox (4.32M shares), STATE STREET CORP (2.63M shares), JPMORGAN CHASE & CO (2.18M shares), and MORGAN STANLEY (1.79M shares).
This table shows the top 377 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.